Texting for Diabetes @ Medicine 2.0’11 Stanford
For Medicine 2.0 (#med2) at Stanford this month, I am excited to be delivering a Research in Progress presentation of our study, “Impact of Texting and Predictive Potential of Health Literacy on Medication Adherence in Type 2 Diabetes Mellitus”. The study, supported by the McKesson Foundation Mobilizing for Health grant program, aims to help a diverse and largely uninsured and underinsured population in South Florida improve adherence to the medications they take for type 2 diabetes mellitus. Our study intervention is designed as a simple series of text messages through treatment targeting one of the primary hurdles to optimal medication adherence – reminders. I will also be sharing our plan for integrating health literacy assessments and disease state knowledge into the clinic EHR as a means to provide more patient-centric counseling and support. Our hope is that we produce an effective intervention to improve health which is also low-cost and thus ultimately scalable. There are a lot of scary numbers being bandied about for diabetes such as its $174 billion annual cost and forecasts that as many as 1 in 3 Americans could develop diabetes by 2050; it would be massive if this contribution could assist in stemming the tide.
Beyond being surrounded by a great study team, I have also been fortunate that providers at our primary care clinic partners have become very enthused about the study. We actually amended our original protocol to account for the fact that physicians at other clinics within the Memorial Healthcare System approached us and volunteered to help recruit participants.
Over the years, Mednet and its offspring, the Medicine 2.0 Congress have been among the most ambitious, surprising, and practically beneficial conferences I’ve attended. Every year I see new attendees from seemingly disparate areas and sectors that come and then find commonalities that produce stimulating discussions, research collaborations, business ventures, and even friendships. This year will continue that tradition with the pre-conference lineup at the Stanford Summit on September 16, 2011 and the two-day Medicine 2.0 conference proper that follows on September 17th and 18th. I will be there to share our research to date and eager to participate in the other sessions. I hope to see you there too!
- RT @DShaywitz: Terrific read (h/t @john_chilmark) & against points 2 prob of optimizing isolated variable forbes.com/sites/davidsha… https://t… 22 hours ago
- RT @duncancraigucl: "We don't have an oversupply - we have an underutilisation" Ash Soni at @School_Pharmacy Stdnt Awards @ashsoni0607 http… 22 hours ago
- RT @DrBonnie360: getting closer to #autoimmune integrated care from #MedX 2015 and 2014! bit.ly/1O6DIqL #autoimmunity https://t.… 22 hours ago
- The New “Disrupters” in Healthcare – #Patients and #Pharmacists by Rajiv Shah, M.D. at @TEDxFargo on.fb.me/1Oe6OnU via @APhAASP #s4pm 2 days ago
- RT @Doctor_V: A team at MIT has done the math and concluded that a doctor can only do so much during a 7 minute encounter https://t.co/kTe2… 2 days ago